Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 10

Results: 18

Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1742, doi. 10.1093/neuonc/noae082

By:

Wang, Justin Z;
Landry, Alexander P;
Raleigh, David R;
Sahm, Felix;
Walsh, Kyle M;
Goldbrunner, Roland;
Yefet, Leeor S;
Tonn, Jörg C;
Gui, Chloe;
Ostrom, Quinn T;
Barnholtz-Sloan, Jill;
Perry, Arie;
Ellenbogen, Yosef;
Hanemann, C Oliver;
Jungwirth, Gerhard;
Jenkinson, Michael D;
Tabatabai, Ghazaleh;
Mathiesen, Tiit I;
McDermott, Michael W;
Tatagiba, Marcos

Publication type:

Article

Expression of Concern: microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.

Published in:: 2024
Publication type:: Correction Notice

Society News: Forthcoming Meetings.

Published in:: Neuro-Oncology, 2024, v. 26, n. 10, p. 1948, doi. 10.1093/neuonc/noae159
Publication type:: Article

Corrigendum to: LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement.

Published in:: 2024
Publication type:: Correction Notice

Temozolomide use in elderly patients with MGMT promoter unmethylated glioblastoma: Is it finally time to dismount a dead horse?

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1876, doi. 10.1093/neuonc/noae143

By:

Sener, Ugur T;
Sulman, Erik P;
Sarkaria, Jann N

Publication type:

Article

Tools and toys beyond RANO 2.0: Digital flipbooks to monitor brain tumor growth dynamics?

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1837, doi. 10.1093/neuonc/noae141

By:

Rhun, Emilie Le;
Weller, Michael

Publication type:

Article

Erratum to: QOL-14. EPILEPTIC SEIZURES, ANTI-SEIZURE MEDICATIONS, AND NEUROCOGNITION IN SURVIVORS OF PEDIATRIC BRAIN TUMORS.

Published in:: 2024
Publication type:: Correction Notice

IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1850, doi. 10.1093/neuonc/noae126

By:

Hou, Andrew J;
Shih, Ryan M;
Uy, Benjamin R;
Shafer, Amanda;
Chang, ZeNan L;
Comin-Anduix, Begonya;
Guemes, Miriam;
Galic, Zoran;
Phyu, Su;
Okada, Hideho;
Grausam, Katie B;
Breunig, Joshua J;
Brown, Christine E;
Nathanson, David A;
Prins, Robert M;
Chen, Yvonne Y

Publication type:

Article

A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1895, doi. 10.1093/neuonc/noae120

By:

Golbourn, Brian;
Ho, Ben;
Bondoc, Andrew;
Luck, Amanda;
Fan, Xiaolian;
Richardson, Elizabeth;
Marcellus, Richard;
Prakesch, Michael;
Halbert, Mathew;
Agrawal, Nishant;
Smith, Christian;
Huang, Annie;
Rutka, James T

Publication type:

Article

The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1912, doi. 10.1093/neuonc/noae114

By:

Abu-Arja, Mohammad H;
Brown, Austin L;
Su, Jack M;
Okcu, M Fatih;
Lindsay, Holly B;
McGovern, Susan L;
McAleer, Mary Frances;
Grosshans, David R;
Chintagumpala, Murali M;
Paulino, Arnold C

Publication type:

Article

Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1933, doi. 10.1093/neuonc/noae112

By:

Nakase, Taishi;
Guerra, Geno A;
Ostrom, Quinn T;
Ge, Tian;
Melin, Beatrice S;
Wrensch, Margaret;
Wiencke, John K;
Jenkins, Robert B;
Eckel-Passow, Jeanette E;
(GICC), Glioma International Case-Control Study;
Bondy, Melissa L;
Francis, Stephen S;
Kachuri, Linda

Publication type:

Article

Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1878, doi. 10.1093/neuonc/noae109

By:

Chen, Yanling;
Zhuo, Ran;
Sun, Lichao;
Tao, Yanfang;
Li, Gen;
Zhu, Frank;
Xu, Yunyun;
Wang, Jianwei;
Li, Zhiheng;
Yu, Juanjuan;
Yin, Hongli;
Wu, Di;
Li, Xiaolu;
Fang, Fang;
Xie, Yi;
Hu, Yizhou;
Wang, Hairong;
Yang, Chun;
Shi, Lei;
Wang, Xiaodong

Publication type:

Article

No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1867, doi. 10.1093/neuonc/noae108

By:

Hegi, Monika E;
Oppong, Felix B;
Perry, James R;
Wick, Wolfgang;
Henriksson, Roger;
Laperriere, Norman J;
Gorlia, Thierry;
Malmström, Annika;
Weller, Michael

Publication type:

Article

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1805, doi. 10.1093/neuonc/noae107

By:

Bent, Martin J van den;
French, Pim J;
Brat, Daniel;
Tonn, Joerg C;
Touat, Mehdi;
Ellingson, Benjamin M;
Young, Robert J;
Pallud, Johan;
Deimling, Andreas von;
Sahm, Felix;
Branger, Dominique Figarella;
Huang, Raymond Y;
Weller, Michael;
Mellinghoff, Ingo K;
Cloughsey, Tim F;
Huse, Jason T;
Aldape, Kenneth;
Reifenberger, Guido;
Youssef, Gilbert;
Karschnia, Philipp

Publication type:

Article

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1781, doi. 10.1093/neuonc/noae103

By:

Wilcox, Jessica A;
Chukwueke, Ugonma N;
Ahn, Myung-Ju;
Aizer, Ayal A;
Bale, Tejus A;
Brandsma, Dieta;
Brastianos, Priscilla K;
Chang, Susan;
Daras, Mariza;
Forsyth, Peter;
Garzia, Livia;
Glantz, Michael;
Oliva, Isabella C Glitza;
Kumthekar, Priya;
Rhun, Emilie Le;
Nagpal, Seema;
O'Brien, Barbara;
Pentsova, Elena;
Lee, Eudocia Quant;
Remsik, Jan

Publication type:

Article

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1839, doi. 10.1093/neuonc/noae102

By:

Kinslow, Connor J;
Roy, Soumyajit;
Iwamoto, Fabio M;
Brown, Paul D;
DeStephano, David M;
Canoll, Peter D;
Qureshi, Summer S;
Gallito, Matthew;
Sisti, Michael B;
Bruce, Jeffrey N;
Horowitz, David P;
Kachnic, Lisa A;
Neugut, Alfred I;
Yu, James B;
Mehta, Minesh P;
Cheng, Simon K;
Wang, Tony J C

Publication type:

Article

Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1823, doi. 10.1093/neuonc/noae097

By:

Cho, Nicholas S;
Le, Viên Lam;
Sanvito, Francesco;
Oshima, Sonoko;
Harper, Jayla;
Chun, Saewon;
Raymond, Catalina;
Lai, Albert;
Nghiemphu, Phioanh L;
Yao, Jingwen;
Everson, Richard;
Salamon, Noriko;
Cloughesy, Timothy F;
Ellingson, Benjamin M

Publication type:

Article

Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1921, doi. 10.1093/neuonc/noae091

By:

Park, Yae Won;
Jang, Geon;
Kim, Si Been;
Choi, Kaeum;
Han, Kyunghwa;
Shin, Na-Young;
Ahn, Sung Soo;
Chang, Jong Hee;
Kim, Se Hoon;
Lee, Seung-Koo;
Jain, Rajan

Publication type:

Article